Jefferies Financial Group Inc. Organon & Co. Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $1.93 Million - $2.46 Million	100,000 New	100,000 $2.08 Million
Q4 2022 Sep 21, 2023	SELL	$23.31 - $28.61 $699,300 - $858,300	-30,000 Reduced 30.0%	70,000 $1.96 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $1.63 Million - $2 Million	70,000 New	70,000 $1.96 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.